AcelRx Pharmaceuticals In...

NASDAQ: ACRX · Real-Time Price · USD
0.86
0.06 (7.50%)
At close: Jan 09, 2024, 10:00 PM

AcelRx Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
8.86M 5.72M 15.28M 12.66M
Short-Term Investments
n/a 3.66M 495K 38.97M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
8.82M 8.84M 246K 2.17M
Receivables
n/a n/a 309K 160K
Inventory
n/a n/a 1.18M 1.11M
Other Current Assets
554K 2.17M 2.31M 2.59M
Total Current Assets
9.42M 11.56M 24.57M 55.49M
Property-Plant & Equipment
n/a n/a 13.86M 20.23M
Goodwill & Intangibles
n/a 8.82M 8.82M n/a
Total Long-Term Assets
8.82M 8.84M 22.92M 22.4M
Total Assets
18.24M 20.39M 47.49M 77.89M
Account Payables
670K 1.34M 2.04M 2.12M
Deferred Revenue
n/a n/a 115K 86K
Short-Term Debt
n/a n/a 7.46M 9.86M
Other Current Liabilities
1.98M 3.18M 4.15M 6.44M
Total Current Liabilities
2.65M 4.51M 13.77M 18.51M
Long-Term Debt
n/a n/a 2.96M 8.76M
Other Long-Term Liabilities
7.59M 1.78M 7.91M 81K
Total Long-Term Liabilities
7.59M 1.78M 11.9M 95.28M
Total Liabilities
10.23M 6.29M 25.67M 113.79M
Total Debt
n/a n/a 8.32M 18.62M
Common Stock
17K 17K 8K 137K
Retained Earnings
-457.23M -444.23M -425.83M -473.58M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
8M 14.11M 21.81M -35.89M
Total Investments
n/a 3.66M 495K 38.97M